CHG-2022-0215

Facility Change for Immunovant-α. Labeling Change for Immunovant-α — major revision. Impacts 4 markets and 5 variations.

Change Number
CHG-2022-0215
Type
Facility Change
Product
Immunovant-α
Status
Draft
Owner
Tomoko Ikeda
Initiated
2023-12-09
Description

Labeling Change for Immunovant-α — major revision

Impacted Markets (4)
BR — BrazilAR — ArgentinaAT — AustriaPT — Portugal
Impacted Modules
3.2.S2.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved